Wednesday, December 21, 2011

FDA to investigate death of patient who was prescribed Gilenya?

English: Logo of the .
Image via Wikipedia
News today that follows the report earlier this month on Gilenya:

The FDA has received a report of a patient with MS who died within 24 hours of taking the first dose of Gilenya.   

FDA has said it cannot conclude whether the drug  resulted in the patient's death, but was evaluating the case.
The patient was also treated with two other drugs, and had completed 6 hours of monitoring after the first Gilenya dose without incident.
The drug's maker said it was investigating whether Gilenya caused the death of a 59-year-old patient who had just started therapy with the drug. 

Enhanced by Zemanta